ArticleNature cancer2021

LILRB3 supports acute myeloid leukemia development and regulates T-cell antitumor immune responses through the TRAF2-cFLIP-NF-κB signaling axis.

Guojin Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.